Archives

Reading Food Labels Carefully

img013If you’re not careful, you can easily misread a label. This will affect your blood sugar, your weight, and bolus rate. Read the info in the box labeled Nutrition Facts. There are four large muffins in this container, however, you are only supposed to eat a half of a muffin per meal. This is an excellent rule of thumb for nondiabetics as well. You still make insulin. When you eat, your brain signals the pancreas to deliver insulin found in the Beta cells depending on your blood sugar, and what you eat. If you haven’t eaten and your blood sugar drops, your brain signals the pancreas to release reserved sugar located in the Alpha cells to prevent fatigue. Overworking either cell can cause havoc on the body.

Half muffin is 24 carbs. (Note- Always subtract fiber from total carbs that are 5 grams and higher) 24 carbs-6 grams of fiber= 18 carbs.

The fiber in food that is 5 g or high is not digested. Therefore you subtract it. If you don’t  you will miscalculate your insulin dosage and have unexplained low blood sugars and increased weight gain.

A balanced breakfast would be:

1/2 muffin  (18 carbs)

1 c. plain yogurt or milk (15 carbs)

1 egg (0 carbs)

2 sm turkey sausages ( Note: you might have to bolus for a veggie sausage. Read carb count)

1/2 fruit of your choice (11-15 carbs)

 

 

 

Class Action Suit Against Novo Nordisk (Insulin Nation)

The Class-Action Lawsuit Against Novo Nordisk
It’s alleged that price fixing to keep the price of insulin high may have obscured trouble with the company’s bottom line.

Insulin_Nation_Novo_Nordisk_Class_Action_Lawsuit_945px

editor | January 23rd 2017

Have you ever fantasized about suing drugmakers who jack up the price of insulin? Novo Nordisk is being sued for its drug pricing, but not by its customers.

sponsor

A class action lawsuit has been filed against Novo Nordisk by a group of investors who say they were misled about earnings forecasts. It’s alleged the drugmaker hid market trouble by colluding with other drug companies to keep the price of insulin artificially high. The lawsuit was filed by Bernstein Litowitz Berger & Grossmann LLP on behalf of the Lehigh County (PA) Employees’ Retirement System, but it can include anyone who invested in Novo Nordisk between April 30, 2015, to October 27, 2016.

(As much as it may seem like buying a vial of Novo insulin is expensive enough for one to be considered an investor in the company, the lawsuit does not include customers.)

The suit seems to stem from an overly optimistic earnings forecast in early 2016 that projected long-term growth of 10 percent, according to a Law360 report. That projection was fueled by triple-digit growth for its new basal insulin, Tresiba, according to a Motley Fool report. Novo’s plan was for Tresiba to become the Lantus-killer in the basal insulin market, but that dream was derailed with Eli Lilly’s December release of Basaglar, a biosimilar (read “generic”) version of Lantus. With Basaglar on the horizon and increasing public unease over high drug prices, pharmacy benefits managers have been able to negotiate steep discounts with insulin makers or exclude some expensive brands altogether. This has cut into sales of Tresiba and Victoza, a GLP-1 drug.

Novo stock, which had been trading at more than $53 a share a year ago stands at $35.73 as of January 17, 2017. In 2016, Novo’s CEO stepped down, and the company announced plans to cut 1,000 jobs.

The 2016 presidential election also brought a high level of uncertainty to the business plans of insulin makers. In October, two prominent lawmakers asked the Justice Department to investigate insulin price fixing. Pharma companies bracing for increased regulation under Hillary Clinton rallied when Donald Trump surprised nearly everyone by winning the electoral college vote. That rally proved fragile, however, as Trump has periodically made overtures about curbing drug prices. Most recently, during a wide-ranging press January 11 press conference, Trump said drug companies were “getting away with murder.” That was enough to send drug company stock value tumbling, according to a CNN Money report.

So far there has been no word of copycat class action lawsuits from investors with the other insulin-making companies.

Can An Insulin Pump Be Mistaken For A Weapon?

732 murders of people of color.

Police said they had a weapon.

Police said book was a weapon.

People said Sandra Bland didn’t put out her cigarette in the car that she drove.

Police said  they feared for their lives.

Can my insulin pump be mistaken for a weapon?

Can my lancet pen be mistaken for a weapon?

Can my glucose meter be mistaken for a weapon?

If my CGM cause my pump to alarm, will I be pulled over?

Will I be shot?

When you are a person of color with diabetes, you have to ask these questions.

 

 

The Highs and Lows of Hypos and Hypers

When I feel nauseous from hyperglycemia, or  irritable from  hypoglycemia symptoms I treat them as if they’ll  last . Don’t makes a plans for  a date, a movie or a dinner  because I predict that I’ll still be tired. Yup, even if you plan meeting a year from now.

“How do you know you’ll be sick next week?” a friend asked.

“I just know.”

“Are you going to the wedding next month?”

“Nooo, I’ll might be sick. I’m tired.”

Diabetes sick days put me in a stupor. Sometimes, sometimes they  cause me to lay all my last days demands in writing. But when I increase those basal rates for my insulin pump,  or eat those disgusting glucose tablets in a few hours I’m relieved of all negative thoughts.